New antidepressant drug opens up important treatment and safety options.
D000328:Adult; D000368:Aged; D000818:Animals; D000928:Antidepressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D000929:Antidepressive Agents, Tricyclic / Q000009:adverse effects; D003866:Depressive Disorder / Q000188:drug therapy*; D006801:Humans; D009025:Morpholines / Q000627:therapeutic use*; D009638:Norepinephrine / Q000037:antagonists & inhibitors; D000077593:Reboxetine
D000928:Antidepressive Agents; D000929:Antidepressive Agents, Tricyclic; D009025:Morpholines; D000077593:Reboxetine; D009638:Norepinephrine